Annual EBIT
-$5.62 M
+$4.62 M+45.14%
December 1, 2023
Summary
- As of March 6, 2025, CELZ annual earnings before interest & taxes is -$5.62 million, with the most recent change of +$4.62 million (+45.14%) on December 1, 2023.
- During the last 3 years, CELZ annual EBIT has risen by +$29.48 million (+83.99%).
- CELZ annual EBIT is now -123.93% below its all-time high of $23.49 million, reached on December 31, 2021.
Performance
CELZ EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.11 M
+$515.60 K+31.72%
September 1, 2024
Summary
- As of March 6, 2025, CELZ quarterly earnings before interest & taxes is -$1.11 million, with the most recent change of +$515.60 thousand (+31.72%) on September 1, 2024.
- Over the past year, CELZ quarterly EBIT has stayed the same.
- CELZ quarterly EBIT is now -103.94% below its all-time high of $28.17 million, reached on March 1, 2021.
Performance
CELZ Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$5.55 M
+$433.50 K+7.25%
September 1, 2024
Summary
- As of March 6, 2025, CELZ TTM earnings before interest & taxes is -$5.55 million, with the most recent change of +$433.50 thousand (+7.25%) on September 1, 2024.
- Over the past year, CELZ TTM EBIT has stayed the same.
- CELZ TTM EBIT is now -123.62% below its all-time high of $23.49 million, reached on December 1, 2021.
Performance
CELZ TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CELZ EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +45.1% | 0.0% | 0.0% |
3 y3 years | +84.0% | +3.9% | +4.9% |
5 y5 years | +54.3% | +3.9% | +4.9% |
CELZ EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -123.9% | +45.1% | -8.8% | +82.3% | -11.9% | +45.8% |
5 y | 5-year | -123.9% | +84.0% | -103.9% | +97.1% | -123.6% | +84.2% |
alltime | all time | -123.9% | +84.0% | -103.9% | +97.1% | -123.6% | +84.2% |
Creative Medical Technology Holdings EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.11 M(-31.7%) | -$5.55 M(-7.2%) |
Jun 2024 | - | -$1.63 M(+56.1%) | -$5.98 M(+7.8%) |
Mar 2024 | - | -$1.04 M(-41.2%) | -$5.55 M(-0.2%) |
Dec 2023 | -$5.62 M(-45.1%) | -$1.77 M(+14.8%) | -$5.56 M(-44.8%) |
Sep 2023 | - | -$1.54 M(+29.5%) | -$10.06 M(+5.5%) |
Jun 2023 | - | -$1.19 M(+13.3%) | -$9.54 M(-5.9%) |
Mar 2023 | - | -$1.05 M(-83.2%) | -$10.14 M(-1.0%) |
Dec 2022 | -$10.24 M(-143.6%) | -$6.28 M(+515.2%) | -$10.24 M(+88.3%) |
Sep 2022 | - | -$1.02 M(-43.0%) | -$5.44 M(+9.7%) |
Jun 2022 | - | -$1.79 M(+55.1%) | -$4.96 M(-15.1%) |
Mar 2022 | - | -$1.15 M(-21.6%) | -$5.84 M(-124.8%) |
Dec 2021 | $23.49 M(-166.9%) | - | - |
Dec 2021 | - | -$1.47 M(+173.6%) | $23.49 M(-276.1%) |
Sep 2021 | - | -$538.30 K(-79.8%) | -$13.34 M(+10.1%) |
Jun 2021 | - | -$2.67 M(-109.5%) | -$12.12 M(+10.2%) |
Mar 2021 | - | $28.17 M(-173.6%) | -$10.99 M(-68.7%) |
Dec 2020 | -$35.10 M(+432.7%) | -$38.30 M(-5698.7%) | -$35.10 M(+2122.1%) |
Sep 2020 | - | $684.10 K(-144.3%) | -$1.58 M(-61.9%) |
Jun 2020 | - | -$1.54 M(-138.0%) | -$4.14 M(+90.0%) |
Mar 2020 | - | $4.07 M(-185.0%) | -$2.18 M(-66.9%) |
Dec 2019 | -$6.59 M(-46.4%) | -$4.78 M(+154.9%) | -$6.59 M(-1390.0%) |
Sep 2019 | - | -$1.88 M(-551.2%) | $510.70 K(-57.2%) |
Jun 2019 | - | $416.00 K(-221.4%) | $1.19 M(-122.8%) |
Mar 2019 | - | -$342.80 K(-114.8%) | -$5.24 M(-57.4%) |
Dec 2018 | -$12.29 M(+438.9%) | $2.31 M(-293.8%) | -$12.29 M(-22.7%) |
Sep 2018 | - | -$1.19 M(-80.2%) | -$15.90 M(+8.7%) |
Jun 2018 | - | -$6.02 M(-18.6%) | -$14.63 M(+55.1%) |
Mar 2018 | - | -$7.40 M(+471.0%) | -$9.44 M(+313.6%) |
Dec 2017 | -$2.28 M(+200.3%) | -$1.30 M(-1769.1%) | -$2.28 M(+93.6%) |
Sep 2017 | - | $77.60 K(-109.4%) | -$1.18 M(-19.8%) |
Jun 2017 | - | -$823.10 K(+241.8%) | -$1.47 M(+72.1%) |
Mar 2017 | - | -$240.80 K(+25.5%) | -$853.30 K(+12.3%) |
Dec 2016 | -$759.70 K | -$191.90 K(-9.7%) | -$759.60 K(+32.3%) |
Sep 2016 | - | -$212.50 K(+2.1%) | -$574.00 K(+57.2%) |
Jun 2016 | - | -$208.10 K(+41.5%) | -$365.20 K(+127.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$147.10 K(+2234.9%) | -$160.90 K(+673.6%) |
Dec 2015 | -$20.80 K(+7.2%) | -$6300.00(+70.3%) | -$20.80 K(+11.2%) |
Sep 2015 | - | -$3700.00(-2.6%) | -$18.70 K(+0.5%) |
Jun 2015 | - | -$3800.00(-45.7%) | -$18.60 K(+1.1%) |
Mar 2015 | - | -$7000.00(+66.7%) | -$18.40 K(-5.2%) |
Dec 2014 | -$19.40 K(-3.5%) | -$4200.00(+16.7%) | -$19.40 K(+0.5%) |
Sep 2014 | - | -$3600.00(0.0%) | -$19.30 K(0.0%) |
Jun 2014 | - | -$3600.00(-55.0%) | -$19.30 K(-2.0%) |
Mar 2014 | - | -$8000.00(+95.1%) | -$19.70 K(-2.5%) |
Dec 2013 | -$20.10 K(0.0%) | -$4100.00(+13.9%) | -$20.20 K(-1.9%) |
Sep 2013 | - | -$3600.00(-10.0%) | -$20.60 K(-2.4%) |
Jun 2013 | - | -$4000.00(-52.9%) | -$21.10 K(+1.4%) |
Mar 2013 | - | -$8500.00(+88.9%) | -$20.80 K(+3.5%) |
Dec 2012 | -$20.10 K(+1.5%) | -$4500.00(+9.8%) | -$20.10 K(-5.2%) |
Sep 2012 | - | -$4100.00(+10.8%) | -$21.20 K(+2.9%) |
Jun 2012 | - | -$3700.00(-52.6%) | -$20.60 K(+1.5%) |
Mar 2012 | - | -$7800.00(+39.3%) | -$20.30 K(+2.5%) |
Dec 2011 | -$19.80 K(+38.5%) | -$5600.00(+60.0%) | -$19.80 K(+15.1%) |
Sep 2011 | - | -$3500.00(+2.9%) | -$17.20 K(+4.2%) |
Jun 2011 | - | -$3400.00(-53.4%) | -$16.50 K(+15.4%) |
Mar 2011 | - | -$7300.00(+143.3%) | -$14.30 K(0.0%) |
Dec 2010 | -$14.30 K(-53.3%) | -$3000.00(+7.1%) | -$14.30 K(-30.2%) |
Sep 2010 | - | -$2800.00(+133.3%) | -$20.50 K(+1.0%) |
Jun 2010 | - | -$1200.00(-83.6%) | -$20.30 K(-28.0%) |
Mar 2010 | - | -$7300.00(-20.7%) | -$28.20 K(-7.8%) |
Dec 2009 | -$30.60 K(-40.4%) | -$9200.00(+253.8%) | -$30.60 K(-8.1%) |
Sep 2009 | - | -$2600.00(-71.4%) | -$33.30 K(-38.1%) |
Jun 2009 | - | -$9100.00(-6.2%) | -$53.80 K(-4.1%) |
Mar 2009 | - | -$9700.00(-18.5%) | -$56.10 K(+8.7%) |
Dec 2008 | -$51.30 K(+277.2%) | -$11.90 K(-48.5%) | -$51.60 K(+7.1%) |
Sep 2008 | - | -$23.10 K(+102.6%) | -$48.20 K(+63.9%) |
Jun 2008 | - | -$11.40 K(+119.2%) | -$29.40 K(+63.3%) |
Mar 2008 | - | -$5200.00(-38.8%) | -$18.00 K(+40.6%) |
Dec 2007 | -$13.60 K(+871.4%) | -$8500.00(+97.7%) | -$12.80 K(+197.7%) |
Sep 2007 | - | -$4300.00 | -$4300.00 |
Dec 2006 | -$1400.00 | - | - |
FAQ
- What is Creative Medical Technology Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings annual EBIT year-on-year change?
- What is Creative Medical Technology Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly EBIT year-on-year change?
- What is Creative Medical Technology Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings TTM EBIT year-on-year change?
What is Creative Medical Technology Holdings annual earnings before interest & taxes?
The current annual EBIT of CELZ is -$5.62 M
What is the all time high annual EBIT for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high annual earnings before interest & taxes is $23.49 M
What is Creative Medical Technology Holdings annual EBIT year-on-year change?
Over the past year, CELZ annual earnings before interest & taxes has changed by +$4.62 M (+45.14%)
What is Creative Medical Technology Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of CELZ is -$1.11 M
What is the all time high quarterly EBIT for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high quarterly earnings before interest & taxes is $28.17 M
What is Creative Medical Technology Holdings quarterly EBIT year-on-year change?
Over the past year, CELZ quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Creative Medical Technology Holdings TTM earnings before interest & taxes?
The current TTM EBIT of CELZ is -$5.55 M
What is the all time high TTM EBIT for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high TTM earnings before interest & taxes is $23.49 M
What is Creative Medical Technology Holdings TTM EBIT year-on-year change?
Over the past year, CELZ TTM earnings before interest & taxes has changed by $0.00 (0.00%)